A prospective randomized controlled trial analyzing the clinical outcomes and patient satisfaction based on the implementation of the clinical pathway for Enhanced Recovery After Surgery program (ERAS CP) following oblique lumbar interbody fusion (OLIF)

Seoul National University Hospital0 个研究点目标入组 38 人开始时间: 待定最近更新: 2024年4月2日

试验速览

暂无简介。

•A. Patients who are able to ambulate independently for more than 30 minutes (see below for specific screening details):
•i. Patients who, despite intermittent claudication, are able to reach a target distance of more than 30 minutes by taking breaks intermittently during ambulation are included.
•ii. Patients who are able to reach a target distance of more than 30 minutes despite experiencing severe pain are also included.
•B. Patients who visited the neurosurgery outpatient clinic for surgical treatment due to lumbar degenerative disease, requiring 1-2 segmental fixation between lumbar 2 and sacral 1.
•C. Patients who voluntarily agree to participate in the research

•A. Patients who have previously undergone lumbar surgery.
•B. Patients with muscle weakness of Manual Muscle Testing grade 3 or higher.
•C. Patients with coexisting neuropsychiatric disorders, such as depression.
•D. Patients with musculoskeletal diseases (inflammatory, myopathic, etc.) and infections other than lumbar degenerative disease.
•E. Patients with concurrent malignant disease.
•F. Patients who do not wish to participate in the research

发起方